We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current R1MD34 market cap is 51.62B. The company's latest EPS is USD 6.9496 and P/E is 35.08.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.1B | 1.16B | 1.2B | 1.22B | 1.22B |
| Operating Income | 285.1M | 275.83M | 377.43M | 379.68M | 388.28M |
| Net Income | 219.42M | 208.8M | 300.49M | 292.24M | 311.36M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.96B | 3.2B | 3.58B | 4.22B | 4.69B |
| Operating Income | 784.6M | 892.47M | 991.8M | 1.12B | 1.32B |
| Net Income | 621.67M | 474.51M | 779.44M | 897.56M | 1.02B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.74B | 6.91B | 6.81B | 6.87B | 7.22B |
| Total Liabilities | 2.49B | 2.42B | 2.18B | 2.01B | 2.03B |
| Total Equity | 4.25B | 4.48B | 4.63B | 4.86B | 5.2B |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.59B | 4.73B | 5.1B | 6.75B | 6.87B |
| Total Liabilities | 2.09B | 1.84B | 1.74B | 2.62B | 2.01B |
| Total Equity | 2.5B | 2.89B | 3.36B | 4.13B | 4.86B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 286.28M | 559.12M | 961.15M | 1.4B | 325.54M |
| Investing | -148.98M | -190.12M | -223.28M | -269.78M | 2.15M |
| Financing | -151.13M | -390.09M | -726M | -1.12B | -150.76M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 802.26M | 736.72M | 351.15M | 693.3M | 1.4B |
| Investing | -179.86M | -158.46M | -229.92M | -1.16B | -269.78M |
| Financing | -317.29M | -764.63M | -128.36M | 422.87M | -1.12B |
| Market Cap | 51.62B |
| Price to Earnings Ratio | 35.08 |
| Price to Sales Ratio | 7.64 |
| Price to Cash Ratio | 150.25 |
| Price to Book Ratio | 7.36 |
| Dividend Yield | 0.60% |
| Shares Outstanding | 146.91M |
| Average Volume (1 week) | 1 |
| Average Volume (1 Month) | 50 |
| 52 Week Change | 87.24% |
| 52 Week High | 368.70 |
| 52 Week Low | 187.67 |
| Spread (Intraday) | 2.8 (0.79%) |
| Company Name | Resmed Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.resmed.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
